Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) bringing about improved adverse effects such as drowsiness, although the clinical relevance is minimal in the majority of clients – observe the patient for adverse effects (e.If client are not able to resume their normal oral medi